Joint

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Joint (JYNT) posts record sales in Q4 2022, eyes strategic growth

Joint (JYNT) delivered strong financial performance in Q4 2022, driven by record clinic openings and successful marketing initiatives.
While facing challenges such as labor costs and franchise sales impact, the company is focused on margin expansion and strategic growth opportunities.
With a positive outlook for 2023 revenue and adjusted EBITDA, Joint (JYNT) aims to navigate challenges and capitalize on opportunities for sustained success.
The company's commitment to patient care, operational efficiency, and financial planning positions it well for future growth and profitability.

Joint Corp. posts impressive Q1 results amidst digital marketing evolution

Joint Corp. delivered robust Q1 2023 results with strong sales growth and operational performance across its clinic network.
While facing competitive pressures and marketing challenges, the company's focus on efficiency and patient acquisition strategies bodes well for future growth.
Adapting to digital marketing trends and leveraging upcoming events can position Joint Corp. for sustained success and investor confidence.

Joint (JYNT) reports strong Q2 growth, focuses on profitability

Joint (JYNT) reported solid growth in system-wide sales and clinic openings, with profitability around 20% despite challenges.
The company is actively addressing operational issues, optimizing its clinic portfolio, and focusing on cost savings initiatives.
Strategic planning for profitability and efficiency in 2024 and beyond is underway, with a commitment to long-term success.
Partnerships, marketing expansions, and ongoing reviews present opportunities for growth and market expansion for Joint (JYNT).

The Joint Corp. reports stable Q3 earnings, shifts focus to franchises

The Joint Corp. delivered solid financial performance in Q3 2023, with a focus on refranchising and enhancing franchise clinic operations.
Efforts to boost new patient starts and optimize marketing strategies are driving positive trends in conversion rates and sales.
While facing challenges in new patient counts and franchise sales, the company is strategically positioning itself for long-term success.

The Joint Corp. reports robust 2023 performance and strategic growth plans

The Joint Corp. delivered strong financial performance in 2023, with notable growth in sales, revenue, and patient metrics.
Strategic initiatives like refranchising and local store marketing offer growth opportunities and cost-saving potential for the company.
Challenges include managing the transition of company-owned clinics and balancing marketing expenses with revenue growth objectives.
Overall, The Joint Corp. is well-positioned to capitalize on its operational strengths and market opportunities for sustained growth and success.

The Joint Corp. triples franchise sales and boosts financial performance

The Joint Corp. delivered strong financial performance in Q1 2024, marked by revenue growth, improved bottom line, and significant franchise sales growth, supported by robust marketing strategies.
While facing potential risks and challenges, the company's focus on EBITDA, franchise expansion, and talent development positions it well for future growth and operational excellence.
Opportunities in marketing innovation, talent development, and operational efficiency present avenues for sustained growth and value creation, aligning with the company's commitment to performance and brand enhancement.
Overall, The Joint Corp.'s Q1 2024 earnings call highlighted a strategic roadmap for success, emphasizing growth, excellence in patient care, and financial transparency to drive shareholder value.

The Joint Corp. reports revenue growth and strategic focus on clinics

The Joint Corp. reported positive revenue growth in Q2 2024, driven by same-store comps and operational improvements.
While facing financial challenges and impact on franchise sales, the company's strategic focus on clinic optimization and patient loyalty is a key strength.
Future opportunities lie in expanding the clinic network, enhancing profitability, and driving patient loyalty through innovative strategies.
Overall, The Joint Corp. is positioned for growth with a strong foundation of clinics and a focus on improving financial performance and patient experiences.

Joint Corp (JYNT) reports robust Q3 performance amidst operational enhancements

Joint Corp's Q3 2024 earnings call highlighted strong performance metrics, a strategic focus on patient care and operational efficiency, and challenges related to consumer headwinds and refranchising efforts. The company is well-positioned to capitalize on growth opportunities by leveraging its infrastructure and exploring new service offerings.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

The Joint's Q3 results reflect higher general and administrative costs. Revenues benefit from strong royalty fees and advertising revenues.

JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3%

The Joint Corp. (JYNT) Q3 2024 Earnings Call Transcript

The Joint Corp. (JYNT) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate. This compares to loss of $0.05 per share a year ago.

The Joint Corp. (JYNT) Q3 Earnings Match Estimates

SCOTTSDALE, Ariz. , Oct. 29, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, announces its newest sponsorship agreement with Grand Canyon University Athletics.

The Joint Chiropractic is Named the Official Chiropractor of Grand Canyon University Athletics

SCOTTSDALE, Ariz., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will report its third quarter 2024 financial results on Thursday, November 7, 2024, after the market close.

The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results

SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, today announced that it granted equity awards on October 14, 2024 as a material inducement to the employment of the Company's newly hired President and Chief Executive Officer, Sanjiv Razdan.

The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

-Seasoned Franchise Executive to also Join the Company's Board of Directors - SCOTTSDALE, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation's largest franchisor of chiropractic care through The Joint Chiropractic ® network, welcomes Sanjiv Razdan as its President and Chief Executive Officer effective today.

The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer

SCOTTSDALE, Ariz. , Oct. 10, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, has been recognized on the annual Franchise Times Top 400.

The Joint Chiropractic Ranks No. 150 on the Franchise Times Top 400

SCOTTSDALE, Ariz. , Oct. 8, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, proudly celebrates its 25th anniversary with the "Remix Your Health" promotion that brings pricing back to 1999.

The Joint Chiropractic Celebrates 25 Years of Making Quality Chiropractic Care Accessible

SCOTTSDALE, Ariz. , Sept. 12, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, welcomes Beth Gross as the organization's new Senior Vice President of Human Resources.

The Joint Corp. Announces New Senior Vice President of Human Resources

SCOTTSDALE, Ariz. , Aug. 22, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, was named one of the Top 50 Franchises in the May/June 2024 money issue of SUCCESS.

SUCCESS Magazine Names The Joint Chiropractic one of the Top 50 Franchises

SCOTTSDALE, Ariz., Aug. 20, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced that management plans to participate in the 7th Annual B. Riley Securities Consumer & TMT Conference on Thursday, September 12, 2024 at the Sofitel New York.

The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference

This year, The Joint (JYNT) intends to open 60-70 new franchised clinics compared with 104 opened last year.

The Joint (JYNT) Forays Into San Francisco Chiropractic Market

SCOTTSDALE, Ariz. , Aug. 13, 2024 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, has opened its first The Joint clinic in San Francisco, Calif.

The Joint Chiropractic Opens First Location in San Francisco

The Joint Corp. (NASDAQ:JYNT ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants David Barnard - LHA Investor Relations Peter Holt - President and Chief Executive Officer Jake Singleton - Chief Financial Officer Conference Call Participants JP Wollam - ROTH Capital Partners C.J. Dipollino - Craig Hallum Capital Group Nick Sherwood - Maxim Group Operator Good day, and welcome to the Joint Corporation, Second Quarter of 2024 Financial Results Conference Call.

The Joint Corp. (JYNT) Q2 2024 Earnings Call Transcript

The Joint Corp. (JYNT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.01 per share a year ago.

The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates

SCOTTSDALE, Ariz., July 25, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its second quarter 2024 financial results on Thursday, August 8, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results

SCOTTSDALE, Ariz., May 13, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, signed an agreement engaging Capstone Partners, a full-service middle market investment bank with specialization in refranchising.

The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts

SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that President and Chief Executive Officer Peter Holt and Chief Financial Officer Jake Singleton are scheduled to participate in the following upcoming conferences:

The Joint Corp. to Participate in Upcoming Investor Conferences

The Joint Corp. (NASDAQ:JYNT ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief Executive Officer Jake Singleton – Chief Financial Officer Conference Call Participants George Kelly – ROTH Anthony Vendetti – Maxim Group C. J. Dipollino – Craig-Hallum Group Operator Good day, and welcome to The Joint Group Corp. First Quarter 2024 Financial Results Conference Call.

The Joint Corp. (JYNT) Q1 2024 Earnings Call Transcript

The Joint Corp. (JYNT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.15 per share a year ago.

The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates

- Grew Q1 2024 Revenue 5%, System-wide Sales 9%, and System-wide Comp Sales 3% vs. Q1 2023 - - Opened 23 Franchised Clinics, Increasing Clinic Count to 954 at March 31, 2024 - - Sold 15 Franchise Licenses, Tripling Sales Compared to Q4 2023 -

The Joint Corp. Reports First Quarter 2024 Financial Results

SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close.

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results

DENVER , April 17, 2024 /PRNewswire/ -- The Joint Chiropractic, the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, is proud to announce a year-long sponsorship of Rachel's Challenge, a non-profit organization for school violence prevention. The Joint is honored to be joining Rachel's Challenge in its vision to create schools full of hope, free from harassment, violence, and self-harm, where teachers are free to teach and students are inspired to learn.

The Joint Chiropractic Proudly Supports Colorado-Based Rachel's Challenge

ST. LOUIS , April 2, 2024 /PRNewswire/ -- Logan University and The Joint Corp. are proud to establish The Joint Chiropractic Endowed Scholarship for Logan's Doctor of Chiropractic students. This scholarship is aimed at supporting and empowering Logan's exceptional students in their pursuit of higher education.

News for Joint Stock (JYNT)